Monoclonal Gammopathy of Undetermined Significance (MGUS)

Monoclonal Gammopathy of Undetermined Significance (MGUS) is a condition where an abnormal protein called a monoclonal protein or M protein is found in the blood. This protein is produced by a small number of abnormal plasma cells, which are part of the immune system. MGUS primarily affects the bone marrow and the immune system. Although it usually does not cause symptoms or health problems, it is important because it can sometimes progress to more serious diseases like multiple myeloma or other blood cancers. People with MGUS often have normal blood counts and no organ damage. Regular monitoring is needed to watch for any changes in the condition.

Monoclonal Gammopathy of Undetermined Significance (MGUS) is a premalignant plasma cell disorder characterized by the presence of a monoclonal immunoglobulin (M protein) in the serum without evidence of multiple myeloma or related malignancies. It results from a clonal proliferation of plasma cells in the bone marrow producing a monoclonal protein, typically IgG, IgA, or light chains. MGUS is asymptomatic and lacks CRAB features (hyperCalcemia, Renal failure, Anemia, Bone lesions) that define multiple myeloma. The condition is significant because it carries a risk of progression to multiple myeloma, Waldenström macroglobulinemia, or other lymphoproliferative disorders at a rate of about 1% per year. Diagnosis requires exclusion of malignancy and other causes of monoclonal gammopathy. MGUS is common in older adults and is often discovered incidentally during evaluation for unrelated conditions.